Malaria News and Research

Latest Malaria News and Research

NIAID scientists confirm antiviral activity of two lead compounds against HPV

Tamir Biotechnology, Inc. announced today that scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID) reported test results confirming two of our lead compounds showed excellent in vitro antiviral activity and no cellular toxicity at dose levels tested for Human Papillomavirus (HPV).

30 Nov 2010

Researchers synthesize iron compounds that inhibit growth of Mycobacterium tuberculosis

A team of researchers from Spain and Latin America have synthesized two iron compounds that inhibit the in vitro growth of Mycobacterium tuberculosis, the bacteria that causes tuberculosis. Due their low level of toxicity in mammel cells, the compounds could be used in the future as therapeutic agents and hospital disinfectants.

26 Nov 2010

Opinions: The Pope and condoms; fighting HIV/AIDS in South Africa; malaria eradication or control; health care workers; foreign aid in Haiti

Reflecting on Pope Benedict XVI's recent statements regarding the use of condoms to prevent the transmission of HIV, Michael Gerson writes in a Washington Post column.

24 Nov 2010

AHF commends Congressman Rohrabacher for exposing AIDS funding grab by China

AIDS Healthcare Foundation (AHF), today lauded California Congressman Dana Rohrabacher (R-46th) for recent comments exposing an AIDS funding grab by the country of China—now the world's second largest economy— in its dealings with the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM). In a speech last week on the House floor, Rohrabacher chided China for its dealings with the Fund.

24 Nov 2010

Preclinical trial shows Chimerix’s CMX001 inhibits HSV replication

Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced that data demonstrating preclinical efficacy of Chimerix's lead antiviral compound CMX001 against herpes simplex virus (HSV) as well as its ability to penetrate the blood-brain barrier was published in the November 15, 2010 issue of The Journal of Infectious Diseases.

23 Nov 2010

IVCC receives $50 million to develop new insecticides

The Innovative Vector Control Consortium has received $50 million from the Bill & Melinda Gates Foundation to continue its work to develop new insecticides for the improved control of mosquitoes and other insects which transmit malaria, dengue and other neglected tropical diseases.

22 Nov 2010

Children's Surgical Centre offers no-cost surgery for children with frontoethmoidal meningoencephalocele

Frontoethmoidal meningoencephalocele is a type of facial malformation that is rarely seen in developed countries, but is quite common in many Southeast Asian countries, occurring in 1 of every 5,000 live births.

20 Nov 2010

New international guidelines launched to protect health workers against HIV, TB

Health workers are at the frontline in providing prevention, treatment and care for people living with HIV and TB throughout the world. They are at risk of occupational exposure to HIV and TB but often themselves lack adequate access to protection and treatment. To address this gap, new international guidelines are being launched today by the International Labour Organization, WHO and the Joint United Nations Programme on HIV/AIDS.

20 Nov 2010

One-third of malaria-endemic countries are complying with WHO malaria drug efficacy monitoring standards, report says

Thirty-four percent of malaria-endemic countries are complying with WHO guidelines to monitor artemisinin resistance within their borders, the agency said in a report on Thursday, CBS News reports (11/18). Reuters reports that artemisinin "is the best drug available against malaria, especially when used in artemisinin combination therapy (ACT), which combines it with other drugs that finish off the [malaria] parasite" (Nebehay, 11/18).

20 Nov 2010

Recent releases in Global Health

New This Week In The Kaiser Global Health Policy Tracker: The President's Malaria Initiative announced a new focus country and USAID released a new fact sheet on the agency's reform initiative. Kaiser's Policy Tracker provides a timely single reference point for the latest information on congressional and administration action on global health.

20 Nov 2010

U.S. falling short of its goals to improve access to clean water, sanitation worldwide, report says

The U.S. is falling short on its goal of improving conditions for the 2.6 billion people worldwide without access to clean water and sanitation despite the fact the Water for the Poor Act became law in 2005, according to a report released Thursday by the Natural Resources Defense Council (NRDC), WaterAid, CARE and 11 other organization, Food Safety News reports.

19 Nov 2010

National monitoring essential for preventing emergence of malaria drug resistance

WHO is calling on countries to be increasingly vigilant in monitoring antimalarial drug efficacy in order to allow for early detection of artemisinin resistance.1 This is one among several conclusions of the Global report on antimalarial drug efficacy and drug resistance: 2000-2010, released today. The report is based on 1100 studies conducted by national malaria control programs and research institutes over the ten-year period.

19 Nov 2010

First Global Symposium on Health Systems Research kicks off in Switzerland

The First Global Symposium on Health Systems Research bringing together researchers, policymakers and donors kicked off in Montreux, Switzerland, on Tuesday, with some conference attendees calling for African leaders to do more to promote health progress in their countries, PANA/Afrique en ligne reports.

18 Nov 2010

Inovio achieves positive results in Phase I PENNVAX-B study for HIV

Inovio Pharmaceuticals, Inc. , a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has achieved high vaccine-induced response rates and strong magnitude of immune responses in its Phase I clinical study of PENNVAX-B, a DNA vaccine for the prevention of HIV infection.

18 Nov 2010

Study reveals true effects of malaria on African generations

Almost a third of cerebral malaria survivors developed epilepsy or other behavioral disorders in the most comprehensive study to date of the disease in African children, solidifying the link between malaria and neuropsychiatric disorders that affect hundreds of thousands of children.

17 Nov 2010

Chimerix’s lipid-conjugated drugs reduces nephrotoxicity: Study

Scientists from Chimerix, Inc. today presented in vitro data demonstrating that the company's lipid-conjugated drugs, CMX001 and CMX157, are not substrates for the human Organic Anion Transporters (hOATs) and thus have significantly reduced potential to cause nephrotoxicity via this mechanism.

17 Nov 2010

Swissmedic approves use of plasma components treated with Cerus' INTERCEPT Blood System

Cerus Corporation announced today that the Swiss regulatory body, Swissmedic, has approved the use of plasma components treated with Cerus' INTERCEPT Blood System.

17 Nov 2010

NPR reports on dengue vaccine progress

NPR's Shots blog examines progress in the search for a vaccine to protect against the dengue virus. WHO estimates that 2.5 billion people worldwide are at risk of getting dengue, and most of them are in Asia and Latin America, the blog writes.

16 Nov 2010

Inovio third quarter total revenue decreases from $3.6 million to $1.3 million

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended September 30, 2010.

15 Nov 2010

Report documents increase in R&D projects on developing world diseases

Drugmakers are now working on over 100 R&D projects designed to tackle diseases of the developing world and almost 80% of them are being carried out with non-industry partners, according to a report released on Wednesday by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).

15 Nov 2010

Malaria News and Research

Latest Malaria News and Research

NIAID scientists confirm antiviral activity of two lead compounds against HPV

Researchers synthesize iron compounds that inhibit growth of Mycobacterium tuberculosis

Opinions: The Pope and condoms; fighting HIV/AIDS in South Africa; malaria eradication or control; health care workers; foreign aid in Haiti

AHF commends Congressman Rohrabacher for exposing AIDS funding grab by China

Preclinical trial shows Chimerix’s CMX001 inhibits HSV replication

IVCC receives $50 million to develop new insecticides

Children's Surgical Centre offers no-cost surgery for children with frontoethmoidal meningoencephalocele

New international guidelines launched to protect health workers against HIV, TB

One-third of malaria-endemic countries are complying with WHO malaria drug efficacy monitoring standards, report says

Recent releases in Global Health

U.S. falling short of its goals to improve access to clean water, sanitation worldwide, report says

National monitoring essential for preventing emergence of malaria drug resistance

First Global Symposium on Health Systems Research kicks off in Switzerland

Inovio achieves positive results in Phase I PENNVAX-B study for HIV

Study reveals true effects of malaria on African generations

Chimerix’s lipid-conjugated drugs reduces nephrotoxicity: Study

Swissmedic approves use of plasma components treated with Cerus' INTERCEPT Blood System

NPR reports on dengue vaccine progress

Inovio third quarter total revenue decreases from $3.6 million to $1.3 million

Report documents increase in R&D projects on developing world diseases

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Malaria News and Research

Latest Malaria News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in